Synthesis and in vitro biological activity of cyclic lipophilic χ-conotoxin MrIA analogues

International Journal of Peptide Research and Therapeutics

Volumn 13, Issue 1-2, 2007, Pages 307-312

  Dekan, Zoltan ^a   Paczkowski, Filip A ^a   Lewis, Richard J ^a   Alewood, Paul F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cyclic conotoxin; Cyclic lipopeptide; Noradrenaline transporter inhibitor; Peptide synthesis

Indexed keywords

CONOTOXIN; CYSTEINE; DEXTRO 2 AMINOTETRADECANOIC ACID MRIA; LAMBDA CONOTOXIN MRIA; NORADRENALIN; NORADRENALIN TRANSPORTER; PEPTIDE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL MODIFICATION; CONTROLLED STUDY; CYCLIZATION; DRUG POTENCY; DRUG SYNTHESIS; IN VITRO STUDY; NONHUMAN; SOLID;

CONUS MARMOREUS;

EID: 34250025418     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-007-9083-2     Document Type: Article

References (18)

1. Adams D. J., Alewood P. F., Craik D. J., Drinkwater R. D., Lewis R. J. (1999). Drug Dev. Res. 46:219-234
2. Adessi C., Soto C. (2002). Curr. Med. Chem. 9:963-978
3. Blanchfield J. T., Dutton J. L., Hogg R. C., Gallagher O. P., Craik D. J., Jones A., et al. (2003). J. Med. Chem. 46:1266-1272
4. Bryan-Lluka L. J., Bonisch H., Lewis R. J. (2003). J. Biol. Chem. 278:40324-40329
5. Flinn N., Coppard S., Toth I. (1996). Int. J. Pharm. 137:33-39
6. Hamman J. H., Enslin G. M., Kotze A. F. (2005). BioDrugs 19:165-177
7. Lovelace E. S., Armishaw C. J., Colgrave M. L., Wahlstrom M. E., Alewood P. F., Daly N. L., et al. (2006). J. Med. Chem. 49:6561-6568
8. Mcintosh J. M., Jones R. M. (2001). Toxicon 39:1447-1451
9. Nielsen C. K., Lewis R. J., Alewood D., Drinkwater R., Palant E., Patterson M., et al. (2005). Pain 118:112-124
10. Pacholczyk T., Blakely R. D., Amara S. G. (1991). Nature 350:350-354
11. Paczkowski, F. A. and Bryan-Lluka, L. J.: 2001, Brain Res. Mol. Brain Res., 97, 32-42
12. Raaijmakers J. M., De Bruijn I., De Kock M. J. (2006). Mol. Plant Microbe Interact. 19:699-710
13. Schnolzer M., Alewood P., Jones A., Alewood D., Kent S. B. (1992). Int. J. Pept. Protein Res. 40:180-193
14. Shao Y., Lu W., Kent S. B. (1998). Tetrahedron Lett. 39:3911-3914
15. Sharpe I. A., Gehrmann J., Loughnan M. L., Thomas L., Adams D. A., Atkins A., et al. (2001). Nat. Neurosci. 4:902-907
16. Sharpe I. A., Palant E., Schroeder C. I., Kaye D. M., Adams D. J., Alewood P. F., et al. (2003). J. Biol. Chem. 278:40317-40323
17. Tam J. P., Lu Y. A., Yu Q. T. (1999). J. Am. Chem. Soc. 121:4316-4324
18. Toth I., Hillery A. M., Wood I. P., Magnusson C., Artursson P. (1994) Int. J. Pharm. 102:223-230